Business Description
Eagle Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US2697961082
Share Class Description:
EGRX: Ordinary SharesDescription
Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology. Its product portfolio consists of four approved products: Argatroban, Ryanodex, Belrapzo, and Bendeka. The company currently has multiple product candidates in advanced stages of development and is under review for approval by the Food and Drug Administration.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 41.34 | |||||
| 9-Day RSI | 45.23 | |||||
| 14-Day RSI | 43.67 | |||||
| 6-1 Month Momentum % | -88.02 | |||||
| 12-1 Month Momentum % | -92.96 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -3.64 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 0.78 | |||||
| PE Ratio without NRI | 0.33 | |||||
| EV-to-EBIT | 1.84 | |||||
| EV-to-EBITDA | 1.16 | |||||
| EV-to-Revenue | 0.25 | |||||
| Earnings Yield (Greenblatt) % | 54.35 | |||||
| FCF Yield % | -101.98 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:EGRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Eagle Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 257.551 | ||
| EPS (TTM) ($) | 0.91 | ||
| Beta | 0.81 | ||
| Volatility % | 117.3 | ||
| 14-Day RSI | 43.67 | ||
| 14-Day ATR ($) | 0.298203 | ||
| 20-Day SMA ($) | 0.773415 | ||
| 12-1 Month Momentum % | -92.96 | ||
| 52-Week Range ($) | 0.0025 - 6.81 | ||
| Shares Outstanding (Mil) | 12.96 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Eagle Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Eagle Pharmaceuticals Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Eagle Pharmaceuticals Inc Frequently Asked Questions
What is Eagle Pharmaceuticals Inc(EGRX)'s stock price today?
The current price of EGRX is $0.71. The 52 week high of EGRX is $6.81 and 52 week low is $0.00.
When is next earnings date of Eagle Pharmaceuticals Inc(EGRX)?
The next earnings date of Eagle Pharmaceuticals Inc(EGRX) is 2024-12-04 Est..
Does Eagle Pharmaceuticals Inc(EGRX) pay dividends? If so, how much?
Eagle Pharmaceuticals Inc(EGRX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers